Determination of Intracellular Esterase Activity Using Ratiometric Raman Sensing and Spectral Phasor Analysis.
Henry J BraddickWilliam J TippingLiam T WilsonHarry S JaconelliEmma K GrantKaren FauldsDuncan GrahamNicholas C O TomkinsonPublished in: Analytical chemistry (2023)
Carboxylesterases (CEs) are a class of enzymes that catalyze the hydrolysis of esters in a variety of endogenous and exogenous molecules. CEs play an important role in drug metabolism, in the onset and progression of disease, and can be harnessed for prodrug activation strategies. As such, the regulation of CEs is an important clinical and pharmaceutical consideration. Here, we report the first ratiometric sensor for CE activity using Raman spectroscopy based on a bisarylbutadiyne scaffold. The sensor was shown to be highly sensitive and specific for CE detection and had low cellular cytotoxicity. In hepatocyte cells, the ratiometric detection of esterase activity was possible, and the result was validated by multimodal imaging with standard viability stains used for fluorescence microscopy within the same cell population. In addition, we show that the detection of localized ultraviolet damage in a mixed cell population was possible using stimulated Raman scattering microscopy coupled with spectral phasor analysis. This sensor demonstrates the practical advantages of low molecular weight sensors that are detected using ratiometric Raman imaging and will have applications in drug discovery and biomedical research.
Keyphrases
- label free
- fluorescent probe
- raman spectroscopy
- living cells
- energy transfer
- high resolution
- quantum dots
- sensitive detection
- single molecule
- optical coherence tomography
- drug discovery
- loop mediated isothermal amplification
- single cell
- hydrogen peroxide
- cell therapy
- induced apoptosis
- oxidative stress
- stem cells
- emergency department
- magnetic resonance imaging
- high speed
- drug delivery
- cell death
- magnetic resonance
- cell proliferation
- reactive oxygen species
- signaling pathway
- solid phase extraction
- bone marrow
- adverse drug
- simultaneous determination